Osaka, Japan

Hidemasa Hikawa

This inventor holds 5 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 3 EPO patents. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2011-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidemasa Hikawa. Retrieved from https://idiyas.com/inventor/hidemasa-hikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 6.2

ph-index = 5

Forward Citations = 149(Granted Patents)


Location History:

  • Funabashi, JP (2013 - 2014)
  • Osaka, JP (2011 - 2015)

Company Filing History:


Years Active: 2011-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Hidemasa Hikawa: Pioneering Innovations from Osaka, JP

Introduction: Hidemasa Hikawa is a renowned inventor hailing from Osaka, Japan, known for his groundbreaking contributions to various technological fields.

Latest Patents: Hikawa's recent patents include advancements in robotics, artificial intelligence, and sustainable energy solutions, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Hidemasa Hikawa has worked with leading research institutions and tech companies, consistently pushing the boundaries of innovation.

Collaborations: Throughout his career, Hikawa has collaborated with top engineers, scientists, and designers, fostering a culture of creativity and excellence in all his projects.

Conclusion: Hidemasa Hikawa's dedication to innovation and his relentless pursuit of technological advancement continue to inspire the next generation of inventors and engineers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…